I can't imagine this is a huge money earner in Aus; surely the opportunity is in the US and all depends on how the integration with PDX goes, but more importantly the take-up with pharmacies and their clients in the US.....the data that becomes a really valuable asset.
We are probably some at least 12 months away from this being even worthwhile in the US, but perhaps refining this in Aus will help the US implementation.
- Forums
- ASX - By Stock
- MDR
- Ann: MedAdvisor Expands Revenue Streams in Clinical Trials
MDR
medadvisor limited
Add to My Watchlist
1.27%
!
7.8¢

Ann: MedAdvisor Expands Revenue Streams in Clinical Trials, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.8¢ |
Change
-0.001(1.27%) |
Mkt cap ! $48.73M |
Open | High | Low | Value | Volume |
7.8¢ | 7.8¢ | 7.7¢ | $37.86K | 486.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 114851 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 114851 | 0.077 |
1 | 200000 | 0.076 |
7 | 260745 | 0.075 |
1 | 60000 | 0.074 |
3 | 350000 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 10000 | 1 |
0.080 | 82136 | 3 |
0.083 | 100000 | 1 |
0.085 | 32040 | 1 |
0.086 | 210000 | 1 |
Last trade - 10.44am 27/06/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online